/2561 June 19, 2018 Subject: Management’s discussion and analysis of the Company’s operating results for Q1/2018 period To: President The Stock Exchange of Thailand DOD Biotech Public Company Limited
Management Discussion and Analysis, Q2/2018 Page 1/3 Ref: IR61/014 10 August 2018 Subject: Management Discussion and Analysis, 2nd Quarter Ending 30 June 2018 To : President The Stock Exchange of
วันที่ 25 กุมภาพันธ์ 2558 August 10, 2018 Subject: Management’s Discussion and Analysis for the 6 months period ended June 30, 2018 Attention: Director and Manager The Stock Exchange of Thailand LDC
Stock Exchange of Thailand Fortune Parts Industry Public Company Limited (“FPI” or “The Company”) would like to submit the reviewed of interim financial statements for the three-month period ended 30 June
-Translation- No. ECF2 041/2561 12 November 2018 Subject: Management Discussion and Analysis of the 3rd quarter ended September 30, 2018 To President The Stock Exchange of Thailand East Coast
ที่ FPI Ref. FPI.024/2018 12 November 2018 Subject : Management Discussion & Analysis of Performance Results of Quarter 3/2018 To : Board of Directors and President of The Stock Exchange of Thailand
Page 1 of 4 No. RJH – SET 16/2019 11 November 2019 Subject : Management’s Discussion and Analysis for the 3rd Quarter of 2019 To : The President The Stock Exchange of Thailand Rajthanee Hospital
ที่ FPI Ref. FPI.007/2020 15 July 2020 Subject : Management Discussion & Analysis of Performance Results of Quarter 1 2020 To : Board of Directors and President of The Stock Exchange of Thailand
Page 1 of 4 No. RJH – SET 9/2020 10 August 2020 Subject : Management’s Discussion and Analysis for the Second Quarter of 2020 To : The President The Stock Exchange of Thailand Rajthanee Hospital
Subject Management Discussion and Analysis for the second quarter ended 30 June 2020 Attention President The Stock Exchange of Thailand According to the resolution of the Board of Directors of JAS Asset